Skip to main content

Table 7 Adjusted* number of subjects who scored Good, Neutral or Poor in terms of CVD risk reduction, from Day 0 to Day 28

From: A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction

Type of FA Score OS™(EPA + DPA + DHA) ω-3 SES E + DSES ω-3 RBCES Total Total minus E + DSES
rTG Good 32 30 32 27 121 89
Concentrated Neutral 0 2 0 5 7 7
Triglyceride Poor 0 0 0 0 0 0
EE Good 30 26 31 16 103 72
Ethyl ester Neutral 0 3 0 15 18 18
  Poor 2 3 1 1 7 6
PL Good 24 15 30 10 79 49
Phospho- Neutral 5 11 0 19 35 35
lipid (krill) Poor 3 6 2 3 14 12
TG Good 26 17 30 9 82 52
Triglyceride Neutral 2 10 0 21 33 33
  Poor 4 5 2 2 13 11
  1. OS™: OmegaScore™; ω-3 SES: Omega-3 Serum Equivalence Score; E + DSES: EPA + DHA Serum Equivalence Score; ω-3 RBCES: Omega-3 Red Blood Cell Equivalence Score.
  2. *“neutral” numbers have been adjusted to exclude subjects whose initial ranking for any of the biomarkers was low risk, and whose ranking did not change from Day 0 to Day 28. These subjects have been re-rated as “good”.